Browsing by Author Devogelaer, Jean-Pierre

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2012Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronateSambrook, Philip; Bucci-Rechtweg, Christina; Devogelaer, Jean-Pierre; Lau, Chak-Sing; Reginster, Jean-Yves; Reid, David; Roux, Christian; Saag, Kenneth G; Su, Guoqin; Northern Clinical School: MedicineBisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate, Bone, vol.50, 1, 2012,pp 289-295
2013Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoidsSambrook, Philip; Bucci-Rechtweg, Christina; Collette, Julien; Devogelaer, Jean-Pierre; Goemaere, Stefan; Ish-Shalom, Sophia; Papanastasiou, Philemon; Reginster, Jean-Yves; Reid, D. M.; Su, Guoqin; Northern Clinical School: MedicineEffect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids, Rheumatology, vol.52, 6, 2013,pp 1058-1069
2011Genome-wide association identifies three new susceptibility loci for Paget's disease of boneHooper, Michael; Albagha, Omar M E; Alonso, Nerea; Brandi, Maria Luisa; Chung, Pui Yan Jenny; Cundy, Tim; Dargie, Rosemary; Devogelaer, Jean-Pierre; et al, various; Goodman, Kirsteen; Visconti, Micaela R; Wani, Sachin; Concord Clinical School: MedicineGenome-wide association identifies three new susceptibility loci for Paget's disease of bone, Nature Genetics, vol.43, 7, 2011,pp 685-689
2007Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronateHooper, Michael; Brown, Jacques P; Curiel, Manuel Diaz; Devogelaer, Jean-Pierre; et, al; Fraser, William D; Hosking, David; Lyles, Kenneth; Miller, Paul; Su, Guoqin; Zelenakas, Ken; Concord Clinical School: MedicineLong-term control of bone turnover in Paget's disease with zoledronic acid and risedronate, JOURNAL OF BONE AND MINERAL RESEARCH 2005, vol.22,(1),2007,pp 142-148
2012Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosisSambrook, Philip; Bucci-Rechtweg, Christina; Devogelaer, Jean-Pierre; Lau, ChakSing; Papanastasiou, Philemon; Reginster, Jean-Yves; Reid, David; Roux, Christian H; Saag, Kenneth G; Su, Guoqin; Northern Clinical School: MedicinePost hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis, Osteoporosis International: with other metabolic bone diseases, vol.23, 3, 2012,pp 1083-1090